Bortezomib exerts its anti-cancer activity through the regulation of Skp2/p53 axis in non-melanoma skin cancer cells and C. elegans.
- Resource Type
- Article
- Authors
- Prabhu, Kirti S.; Ahmad, Fareed; Kuttikrishnan, Shilpa; Leo, Rari; Ali, Tayyiba Akbar; Izadi, Mahmoud; Mateo, Jericha M.; Alam, Majid; Ahmad, Aamir; Al-Shabeeb Akil, Ammira S.; Bhat, Ajaz A.; Buddenkotte, Joerg; Pourkarimi, Ehsan; Steinhoff, Martin; Uddin, Shahab
- Source
- Cell Death Discovery; 5/9/2024, Vol. 10 Issue 1, p1-13, 13p
- Subject
- Language
- ISSN
- 20587716